Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
Active, not recruiting · NCT05111574 · Registry updated 2026-08-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery | anal melanoma, cervix melanoma, esophageal melanoma, gallbladder melanoma, mucosal melanoma, rectum malignant melanoma, vaginal melanoma, vulvar melanoma | Active, not recruiting | Phase 2 | 2026-08-04 | NCT05111574 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
146 results · Page 1 of 6
Research sites
Swipe the table sideways for more columns.